Seragon Biosciences Inc. has announced the launch of Enlivien, an advanced sleep and longevity optimizer designed to address the hidden biological toll of insufficient rest. This next-generation formulation combines a proprietary blend of antioxidant and anti-inflammatory compounds with molecules that support mitochondrial health, targeting the molecular damage caused by chronic […]
Featured News
HopeAI Joins Mayo Clinic Platform to Transform AI-Driven Drug Development
HopeAI, a rising innovator in the application of artificial intelligence (AI) to speed up drug discovery and development, has joined the esteemed Mayo Clinic Platform Accelerate program. Through this collaboration, HopeAI gains access to Mayo Clinic’s exceptional real-world data (RWD) platform, a resource that can transform the way clinical trials […]
Garden Unveils BLOOM to Revolutionize IP Verification in AI Drug Discovery
Garden has introduced BLOOM (Branching Lookup Optimized for Organic Molecules), a Markush structure search engine designed to provide AI-driven drug discovery teams with near-instant verification of small-molecule intellectual property landscapes. This capability enables researchers to refine molecular candidates with legal certainty integrated directly into the design process. As AI models […]
Credentialing Made Easy: Pharmacy Profiles Joins Forces with McKesson’s Health Mart Network
Pharmacy Profiles, a leading provider of pharmacist identity and credentialing solutions, has announced a new partnership with McKesson Corporation to deliver credential verification services for McKesson’s Health Mart network of independent pharmacies. Through this collaboration, Health Mart pharmacies will gain access to Pharmacy Profiles’ secure, pharmacist-focused digital platform, designed to […]
Instylla’s Resorbable Embolic Technology Gets FDA Nod for Hypervascular Tumors
Instylla, Inc., a privately held innovator in resorbable embolic technologies for peripheral vascular embolization, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for its flagship product, the Embrace™ Hydrogel Embolic System (HES). The approval covers the use of Embrace HES for the embolization […]
Freenome and Exact Sciences Join Forces to Commercialize Groundbreaking Blood-Based CRC Test
Freenome, a biotechnology company focused on pioneering early cancer detection, has entered into an exclusive licensing agreement with Exact Sciences to drive forward the commercialization of its blood-based colorectal cancer (CRC) screening test. The agreement gives Exact Sciences the right to market the CRC blood test technology in the United […]
CERTIFY Health and DentalBee Deliver Next-Gen Dental Automation with AI and Engagement Tools
CERTIFY Health, a leading patient-centric practice management platform, has entered into a strategic alliance with DentalBee, a pioneer in AI-driven dental documentation, to revolutionize how dental practices operate. This collaboration aims to streamline dental workflows by uniting CERTIFY Health’s comprehensive patient management technology with DentalBee’s advanced real-time AI scribe and […]
Revolutionizing Transplant Care: BMI OrganBank Receives FDA Nod for Organ Preservation Device
BMI OrganBank, a frontrunner in the field of organ assessment and preservation, has announced a major milestone: its innovative organ preservation device has been granted the Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This recognition, specifically awarded for their novel kidney preservation system, highlights the company’s […]
MiRus’ EUROPA PCF System Secures CMS NTAP Approval for Cervical Spine Innovation
MiRus has announced that its EUROPA® Posterior Cervical Fusion (PCF) System has been granted New Technology Add-on Payment (NTAP) status by the Centers for Medicare and Medicaid Services (CMS), marking a key advancement in spine surgery options. The system’s usage of MoRe, the company’s patented rhenium-based alloy, and its proven […]
Ellipsis Health Joins CMS Health Tech Ecosystem to Advance AI-Driven Patient Care
Ellipsis Health, the developer behind Sage—the emotionally intelligent AI care manager—has been chosen as a key partner in the Health Tech Ecosystem, a pivotal initiative within the Centers for Medicare and Medicaid Services’ (CMS) digital modernization efforts. The announcement marks a significant milestone in healthcare innovation, as Ellipsis Health joins […]
